|
WO2021028772A1
|
|
Cholecalciferol for use in the treatment of celiac disease
|
|
WO2020245780A1
|
|
Process for the preparation of the polymorph f of sodium neridronate
|
|
WO2019048532A1
|
|
Composition for calcium supplementation
|
|
EP3630081A1
|
|
Xibornol for use in the treatment of acne vulgaris
|
|
EP3553067A1
|
|
Polymorph of sodium neridronate and preparation process thereof
|
|
EP3551190A1
|
|
Composition for the treatment of osteoarthritis
|
|
IT201700099708A1
|
|
COMPOSITION FOR SOCCER INTEGRATION
|
|
CA3030657A1
|
|
Use of xibornol as active agent in the treatment of viral infections
|
|
AU2015332060A1
|
|
Use of neridronic acid or of its salt for the treatment of osteoarthrosis
|
|
EP2371816A1
|
|
Aminocyclohexenone, their preparation and use as medicament against oxidative stress
|
|
EP2345639A1
|
|
Cyclic hydroxylamine derivatives, their preparation and use as antioxidants
|
|
WO2011010332A1
|
|
Process for preparing rel-(3r*,3as*,7as*)-3-benzyl-2-methyl-2,3, 3a,4,5,6,7,7a- octahydrobenzo[d]isoxazoi-4-one or a salt thereof
|
|
US2011039902A1
|
|
PROCESS FOR PREPARING A CRYSTALLINE FORM COMPOUND OF 3-BENZYL-2-METHYL-2,3,3a,4,5,6,7,7a-OCTAHYDROBENZO[d]ISOXAZOL-4-ONE
|
|
EP2112142A1
|
|
Process for preparing a crystalline form compound of 3-benzyl-2-methyl-2,3,3a,4,5,6,7,7a-octahydrobenzo[d]isoxazol-4-one
|
|
NZ577978A
|
|
The fumarate salt of 3-benzyl-2-methyl-2,3,3a,4,5,6,7,7a-octahydrobenzo[d]isoxazol-4-one
|
|
AU2007216126A1
|
|
Process for the preparation of 2-(4-hydroxy-3-morfolynil)-2-cyclohexenone
|
|
US2009292129A1
|
|
Process for resolving racemic mixtures and a diastereoisomeric complex of a resolving agent and an enantiomer of interest
|
|
WO2007073921A1
|
|
Pharmaceutical formulation for the treatment of osteoarthritis containing clodronic acid and hyaluronic acid
|
|
CN101076514A
|
|
Derivatives of arylsulfonamido-substituted hydroxamic acid as matrix metalloproteinases inhibitors
|
|
US2006019902A1
|
|
PTH-like peptides
|
